Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuwen Hui"'
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e28047- (2024)
In trauma first aid, rapid hemostasis is a priority, extricating patients from hemorrhagic shock and infection risks. This paper explores novel hemostatic materials, using ion-crosslinking and freeze-drying techniques. Iterative experiments determine
Externí odkaz:
https://doaj.org/article/bed97250868b44f19007a94ae800e3c2
Publikováno v:
Gong-kuang zidonghua, Vol 37, Iss 12, Pp 118-122 (2011)
In view of problems of high packet loss rate and bad expandability existed in traditional network monitoring and control system because of adopting centralized control way, the paper put forward a design scheme of network monitoring and control syste
Externí odkaz:
https://doaj.org/article/02ab761e6f4342189ac3851a76c9714a
Publikováno v:
2015 16th International Conference on Electronic Packaging Technology (ICEPT); 2015, p568-573, 6p
Publikováno v:
2013 14th International Conference on Electronic Packaging Technology; 2013, p1019-1024, 6p
Autor:
Yuwen H; Shanghai Antengene Corporation Limited, Shanghai, P.R. China., Wang H; Oricell Therapeutics Co., Ltd, Shanghai, P.R. China., Li T; Shanghai Antengene Corporation Limited, Shanghai, P.R. China., Ren Y; Shanghai Antengene Corporation Limited, Shanghai, P.R. China., Zhang YK; Antengene Biotech LLC, Doylestown, Pennsylvania., Chen P; Shanghai Antengene Corporation Limited, Shanghai, P.R. China., Sun A; Shanghai Antengene Corporation Limited, Shanghai, P.R. China., Bian G; Shanghai Antengene Corporation Limited, Shanghai, P.R. China., Li B; Oricell Therapeutics Co., Ltd, Shanghai, P.R. China., Flowers D; Applied BioMath LLC, Concord, Massachusetts., Presler M; Applied BioMath LLC, Concord, Massachusetts., Subramanian K; Applied BioMath LLC, Concord, Massachusetts., Xue J; Crown Bioscience Inc., Taicang, P.R. China., Wang J; Crown Bioscience Inc., Taicang, P.R. China., Lynch K; Antengene Pty Ltd, Melbourne, Australia., Mei J; Antengene Corporation Co., Ltd, Shaoxing, P.R. China., He X; Oricell Therapeutics Co., Ltd, Shanghai, P.R. China., Shan B; Antengene Corporation Co., Ltd, Shaoxing, P.R. China., Hou B; Antengene Corporation Co., Ltd, Shaoxing, P.R. China.
Publikováno v:
Cancer research [Cancer Res] 2024 May 15; Vol. 84 (10), pp. 1680-1698.
Autor:
Tang YC; The Key Laboratory of Stem Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China. yctang@sibs.ac.cn angelika@mit.edu., Yuwen H; The Key Laboratory of Stem Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wang K; Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China., Bruno PM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Bullock K; Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Deik A; Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Santaguida S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Trakala M; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Pfau SJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Zhong N; The Key Laboratory of Stem Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China., Huang T; Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wang L; Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China., Clish CB; Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Hemann MT; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Amon A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. yctang@sibs.ac.cn angelika@mit.edu.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2017 Oct 01; Vol. 77 (19), pp. 5272-5286. Date of Electronic Publication: 2017 Aug 03.